sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 501-525 out of 1420.

<< < 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 > >>

Public Release: 27-Mar-2017
Nature Communications
Researchers crack structure of key protein in Zika virus
The genomic replication of the Zika virus (ZIKV) is made possible by its 'NS5' protein. UC Riverside scientists report that they have determined the crystal structure of the entire ZIKV NS5 protein and demonstrated that NS5 is functional when purified in vitro. Knowing the structure of ZIKV NS5 helps the researchers understand how ZIKV replicates itself. Further, the researchers identified the inhibitor-binding site of NS5, enabling scientists to design potential potent drugs to fight ZIKV.
March of Dimes Foundation, Sidney Kimmel Foundation for Cancer Research, National Institutes of Health

Contact: Iqbal Pittalwala
University of California - Riverside

Public Release: 27-Mar-2017
Proceedings of the National Academy of Sciences
A new test to rapidly identify worldwide TB infections
A group of scientists from Arizona, Texas and Washington, D.C., has teamed up to develop the first rapid blood test to diagnose and quantify the severity of active TB cases. Led by Tony Hu, a researcher at Arizona State University's Biodesign Institute, eight research groups, including the Houston Methodist Research Institute and scientists at the National Institutes of Health, are harnessing the new field of nanomedicine to improve worldwide TB control.

Contact: Joe Caspermeyer
Arizona State University

Public Release: 24-Mar-2017
Future Science OA
New lab-on-a-chip platform seeks to improve pathogen detection
Researchers from the Fraunhofer Institute have developed a new prototype lab-on-a-chip platform for the easy and versatile detection of molecular pathogens.

Contact: Leela Ripton
Future Science Group

Public Release: 23-Mar-2017
Scientists assemble Zika virus mosquito genome from scratch
A team of scientists has developed a new way to sequence genomes, which can assemble the genome of an organism, entirely from scratch, dramatically cheaper and faster.

Contact: Graciela Gutierrez
Baylor College of Medicine

Public Release: 23-Mar-2017
Journal of Interferon & Cytokine Research
New understanding of chronic lung inflammatory diseases unfolding
Researchers studying chronic inflammation that can lead to the development of lung diseases such as asthma, pulmonary fibrosis, and cancer, are focusing on the role cytokines play in regulating the behavior of fibroblast cells and the extracellular matrix.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 23-Mar-2017
European Heart Journal
Cardiac lead extractions safer in high volume centers
Cardiac lead extraction is safer in high volume centers, according to the largest study of contemporary practice in Europe published today in European Heart Journal. Extraction in a low volume center was associated with a doubled risk of death while in hospital.
Boston Scientific, Cook Medical, Medtronic, Spectranetics and Zoll

Contact: ESC Press Office
European Society of Cardiology

Public Release: 23-Mar-2017
Most dengue infections transmitted in and around home
Transmission of the mosquito-borne dengue virus appears to be largely driven by infections centered in and around the home, with the majority of cases related to one another occurring in people who live less than 200 meters apart, new research led by the Johns Hopkins Bloomberg School of Public Health and the University of Florida suggests.
NIH/National Institute of Allergy and Infectious Diseases, National Science Foundation, Global Emerging Infections Surveillance and Response System, Armed Services Health Surveillance Health Center

Contact: Stephanie Desmon
Johns Hopkins University Bloomberg School of Public Health

Public Release: 22-Mar-2017
New England Journal of Medicine
New low-cost rotavirus vaccine could reduce disease burden in developing countries
A new vaccine for rotavirus was found to be 66.7 percent effective in preventing severe gastroenteritis caused by the virus, according to a new study from researchers at Harvard T.H. Chan School of Public Health and Epicentre, Paris.
Médecins Sans Frontières, Kavli Foundation

Contact: Todd Datz
Harvard T.H. Chan School of Public Health

Public Release: 21-Mar-2017
Sussex Drug Discovery Centre & ReViral reach clinical trial with lung virus treatment
Sussex Drug Discovery Centre & ReViral reached a clinical trial with a 'game changer' treatment for respiratory syncytial virus.

Contact: Lynsey Ford
University of Sussex

Public Release: 21-Mar-2017
Interferon drug shows promise in treating Ebola
A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.
Canadian Institutes of Health Research, European Mobile Laboratory

Contact: Alex Radkewycz
University Health Network

Public Release: 21-Mar-2017
Molecular Biology and Evolution
HIV co-infection influences natural selection on M. tuberculosis
While M. tuberculosis has been evolving with humans for thousands of years, HIV co-infections create host immunological environments that this bacterium has not encountered before and could, therefore, be nudging it to evolve new characteristics. Now, an evolutionary analysis of M. tuberculosis full genome sequences from HIV uninfected and HIV co-infected individuals uncovered specific sites within M. tuberculosis genomes where the bacterium may have been compelled to evolve in response to HIV-1 co-infections.

Contact: Joseph Caspermeyer
Molecular Biology and Evolution (Oxford University Press)

Public Release: 20-Mar-2017
Scientific Reports
Testing for Zika virus: There's an app for that
Add rapid, mobile testing for Zika and other viruses to the list of things that smartphone technology is making possible. Researchers at Sandia National Laboratories have developed a smartphone-controlled, battery-operated diagnostic device that weighs under a pound, costs as little as $100 and can detect Zika, dengue and chikungunya within 30 minutes.

Contact: Jules Bernstein
DOE/Sandia National Laboratories

Public Release: 20-Mar-2017
Proceedings of the National Academy of Sciences
Vaccine, improved treatment are keys to control of a surging HIV pandemic
Development and widespread use of a vaccine that's even partially effective against HIV, along with more progress toward diagnosis and treatment, offer the best hopes for turning the corner on a global pandemic that's still spiraling out of control, researchers reported today.
National Institutes of Health

Contact: Jan Medlock
Oregon State University

Public Release: 16-Mar-2017
Scientific Reports
New anti-Wolbachia drug regimen could reduce treatment times of LF and Oncho to 1-2 weeks
This week, scientists from the A·WOL Consortium based at the Liverpool School of Tropical Medicine have published a paper entitled 'Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis' in Scientific Reports.

Contact: Clare Bebb
Liverpool School of Tropical Medicine

Public Release: 16-Mar-2017
Zeroing in on the Zika virus
Hobman has been announced as one of three Canadian scientists who have received funding from the Canadian Institutes of Health Research (CIHR) for their teams to study the Zika virus. Hobman's lab has been awarded $500,000 over three years to investigate how the virus changes host cells during infection, with the goal of developing antiviral therapies that can be used against the pathogen. There are currently no antivirals or vaccines available to protect against Zika.
Canadian Institute of Health Research, Li Ka Shing Institute of Virology, Women and Children's Health Research Institute

Contact: Ross Neitz
University of Alberta Faculty of Medicine & Dentistry

Public Release: 16-Mar-2017
European Heart Journal: Acute Cardiovascular Care
Delirium is associated with 5-fold increased mortality in acute cardiac patients
Delirium is associated with a five-fold increase in mortality in acute cardiac patients, according to research published today in European Heart Journal: Acute Cardiovascular Care. Delirium was common and affected over half of acute cardiac patients aged 85 years and older.

Contact: ESC Press Office
European Society of Cardiology

Public Release: 15-Mar-2017
UA part of international alliance to address African antivenom crisis
The African Society of Venimology, the Institute of Biotechnology of the National Autonomous University in Mexico and the VIPER Institute at the University of Arizona partner to provide biotechnology and educational support to confront the snakebite crisis on the African continent.

Contact: George Humphrey
University of Arizona Health Sciences

Public Release: 15-Mar-2017
Angewandte Chemie
New method for producing leading anti-malarial drug
Researchers at Cardiff University have devised a new way of creating a drug commonly used as the first line of defense against malaria around the world.

Contact: Michael Bishop
Cardiff University

Public Release: 15-Mar-2017
European Heart Journal - Cardiovascular Pharmacotherapy
'Harmless' painkillers associated with increased risk of cardiac arrest
Painkillers considered harmless by the general public are associated with increased risk of cardiac arrest, according to research published today in the March issue of European Heart Journal - Cardiovascular Pharmacotherapy.

Contact: ESC Press Office
European Society of Cardiology

Public Release: 15-Mar-2017
Science Translational Medicine
Researchers map pathways to protective antibodies for an HIV vaccine
A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Avery
Duke University Medical Center

Public Release: 14-Mar-2017
Experimental Ebola vaccine regimen induced durable immune response, study finds
A two-vaccine regimen to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published March 14 in JAMA. The investigational vaccines included Ad26.ZEBOV, developed by Janssen Vaccines & Prevention B.V., of the Janssen Pharmaceutical Companies of Johnson & Johnson, and MVA-BN-Filo, developed by Bavarian Nordic. The NIAID supported the development and testing of the experimental vaccines.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 14-Mar-2017
Immune molecule protects against Zika virus infection in animal models
A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found. Administering the molecule, called 25-hydroxycholesterol or 25HC, to pregnant mice reduced Zika virus infection in the fetal brain and protected against Zika-induced microcephaly. The work was supported in part by the National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Hillary Hoffman
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 14-Mar-2017
Ebola vaccines provide immune responses after 1 year
Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.

Contact: Matthew D. Snape, M.D.
The JAMA Network Journals

Public Release: 13-Mar-2017
Georgia State researcher Gets $4.1 million federal grant to develop drug to combat Ebola virus
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.
NIH/National Institute of Allergy and Infectious Diseases

Contact: LaTina Emerson
Georgia State University

Public Release: 13-Mar-2017
Nature Microbiology
Tick tock: Time to sleep? Sleeping parasite has own internal clock
Researchers from iMM Lisboa have shown that the parasite responsible for sleeping sickness, Trypanosoma brucei, has its own internal clock, which allows it to anticipate daytime alterations of its surrounding environment and become more virulent.

Contact: Ana de Barros
Instituto de Medicina Molecular

Showing releases 501-525 out of 1420.

<< < 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 > >>